NCT01669824View on ClinicalTrials.gov

Pharmacy Based Pharmacoepidemiological Observational Study With Aspirin Protect 100 mg

CompletedOBSERVATIONAL

Enrollment

4,235

Participants

Timeline

Start Date

August 31, 2007

Study Completion Date

May 31, 2009

Conditions

AspirinDrug SafetyEffects, Longterm

Interventions

DRUG

Acetylsalicylic acid (Aspirin, BAYE4465)

Aspirin protect (enteric coated aspirin) 100 mg/single dose/day as long-term medication

Trial Locations (1)

Unknown

Multiple Locations

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY